IP Library Granted Patent US 8,550,089
Granted Patent B2
US 8,550,089 · App. 12/765,369 · Granted Oct 8, 2013

Magnetic particles for delivering therapeutic agent to a target location

Inventors: Aiden Flanagan (Galway, IE); Kent Harrison (Maple Grove, MN); Liliana Atanasoska (Edina, MN); David J. Sogard (Edina, MN); Liza J. Davis (St. Michael, MN)
Assignee: Boston Scientific Scimed, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,550,089
App. No.
12/765,369
Granted
Oct 8, 2013
Kind
B2
Abstract

A system for delivering therapeutic agent to a target location in a body in accordance with one embodiment is provided comprising a plurality of magnetic particles, each magnetic particle carrying a therapeutic agent, and a magnetic device for attracting the magnetic particles to a target location. The magnetic particles may be delivered by a catheter into a blood vessel upstream from the target location so that they travel toward the target location. A method for delivering therapeutic agent to a target location in a body in accordance with another embodiment comprises providing a plurality of magnetic particles, each magnetic particle carrying a therapeutic agent, placing a magnetic device in a position to attract the magnetic particles to a target location, and allowing the magnetic particles to infuse the target location by the attraction of the magnetic particles to the magnetic device. The therapeutic agent may comprises a therapeutic agent for preventing or treating reperfusion injury, and the step of providing the plurality of magnetic particles may comprise delivering the plurality of magnetic particles through a blood vessel.

Claims (23)

1. A method of delivering therapeutic agent to a target location in a body comprising:

positioning an angioplasty catheter at an obstruction in a coronary artery for performing an angioplasty procedure, the angioplasty catheter having a perfusion lumen;

conducting the angioplasty procedure at the obstruction in the coronary artery;

infusing a plurality of magnetic particles through the perfusion lumen of the angioplasty catheter into the coronary artery upstream from the target location, each magnetic particle carrying a therapeutic agent, wherein the infusing step is performed simultaneously or nearly simultaneously with the angioplasty procedure;

placing a magnetic device in a position to attract the magnetic particles to the target location, the target location being an area of ischemic myocardium; and

allowing the magnetic particles to infuse the target location by the attraction of the magnetic particles to the magnetic device.

2. The method of claim 1 wherein the therapeutic agent comprises a therapeutic agent for preventing or treating reperfusion injury.

3. The method of claim 2 wherein the magnetic device is placed through the inside of a heart adjacent inside layers of the myocardium wall to attract the magnetic particles to the ischemic myocardium.

4. The method of claim 2 wherein the magnetic device is placed on the outside of a heart to attract the magnetic particles to the ischemic myocardium.

5. The method of claim 1 wherein each of the magnetic particles of the plurality of magnetic particles comprises a magnetic core and a coating in which the therapeutic agent is contained.

6. The method of claim 1 wherein each of the magnetic particles of the plurality of magnetic particles comprises a core in which the therapeutic agent is contained and a coating comprising magnetic material.

7. The method of claim 1 wherein each of the magnetic particles of the plurality of magnetic particles comprises a porous magnetic material loaded with the therapeutic agent.

8. The method of claim 1 wherein each of the magnetic particles of the plurality of magnetic particles comprises a matrix carrying magnetic material and the therapeutic agent.

9. The method of claim 1 wherein each of the magnetic particles of the plurality of magnetic particles is a nanoparticle having a size of 200 nm or less.

10. The method of claim 1 wherein the therapeutic agent comprises an anti-inflammatory agent, a free radical scavenger, or a vasodilator.

11. The method of claim 1 wherein the infusing step is performed simultaneously with the angioplasty procedure.

12. The method of claim 1 wherein the infusing step is performed nearly simultaneously with the angioplasty procedure.

13. A method of delivering therapeutic agent to a target location in a body comprising:

providing a plurality of magnetic particles, each magnetic particle carrying a therapeutic agent;

placing a magnetic device in a position to attract the magnetic particles to a target location; and

allowing the magnetic particles to infuse the target location by the attraction of the magnetic particles to the magnetic device;

wherein the therapeutic agent comprises a therapeutic agent for preventing or treating reperfusion injury, and the step of providing the plurality of magnetic particles comprises delivering the plurality of magnetic particles through a blood vessel; and

wherein the magnetic device is placed on the outside of a heart to attract the magnetic particles to ischemic myocardium.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 22, 2010
From: FLANAGAN, AIDEN; HARRISON, KENT; ATANASOSKA, LILIANA; SOGARD, DAVID; DAVIS, LIZA
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 024273/0579 →
Continuity (2)
Provisional Application 61173432 · Apr 28, 2009
Related Publication 20100269838A1 · Oct 28, 2010